OpenEvidence Safety and Comparative Efficacy of Four LLM's in Clinical Practice
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Hannah K Galvin, MD · PRINCIPAL_INVESTIGATOR · Cambridge Health Alliance
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Clinical Appropriateness: Mean with SD6 months
Clinical appropriateness score of resident decisions based on OpenEvidence output. This is numeric score on a 10-point Likert scale. (For Likert scales described in this and all of our outcome metrics, higher scores are better outcomes.) Mean score with standard deviation will be used for primary outcome.
- Clinical Appropriateness: Median6 months
Clinical appropriateness score of resident decisions based on OpenEvidence output. This is numeric score on a 10-point Likert scale. Median clinical appropriateness scores will also be reported.
- Clinical Appropriateness: Interrater Reliability6 months
SME's will evaluate Clinical Appropriateness scores of resident decisions based on OpenEvidence output on a 10-point Likert scale. Interrater reliability of SME Clinical Appropriateness scores will be calculated using kappa value.